In this retrospective cohort of 159 patients with subarachnoid haemorrhage, UHR PCCT substantially improved lenticulostriate artery (LSA) visualization compared with conventional EID-CTA. For branches arising >5 mm from the MCA origin, PCCT detection approached DSA—for example, 93% vs 85% for observer 1 in the left hemisphere (p = 0.62)—while EID-CTA detected only 49% in the unpaired comparison.
PCCT remained inferior to DSA for depicting the full distal extent of larger LSA branches. Median LSA length >5 mm from the MCA origin was 23 mm on PCCT vs 40 mm on DSA for observer 1, whereas PCCT nevertheless showed significantly longer measurable branches than EID-CTA (23 vs 15 mm, p < 0.001).
The main technical trade-off was dose: the optimized 90-kVp, 0.2-mm UHR PCCT protocol achieved markedly better small-vessel visualization, but CTDIvol ranged 17–27 mGy, above the reported EID-CTA ranges. Thus, PCCT appears promising as a non-invasive alternative for LSA assessment, but DSA remains superior for the most distal branches and prospective clinical validation is needed.